These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35861435)

  • 21. Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.
    van Dessel LF; Beije N; Helmijr JC; Vitale SR; Kraan J; Look MP; de Wit R; Sleijfer S; Jansen MP; Martens JW; Lolkema MP
    Mol Oncol; 2017 Mar; 11(3):295-304. PubMed ID: 28164427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC).
    Sherwood JL; Corcoran C; Brown H; Sharpe AD; Musilova M; Kohlmann A
    PLoS One; 2016; 11(2):e0150197. PubMed ID: 26918901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal Cancer.
    Stasik S; Mende M; Schuster C; Mahler S; Aust D; Tannapfel A; Reinacher-Schick A; Baretton G; Krippendorf C; Bornhäuser M; Ehninger G; Folprecht G; Thiede C
    Front Genet; 2021; 12():811291. PubMed ID: 35069704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Cell-Free DNA Yield and Circulating-Tumor DNA Quantity from Liquid Biopsies of 12 139 Cancer Patients.
    Huang RSP; Xiao J; Pavlick DC; Guo C; Yang L; Jin DX; Fendler B; Severson E; Killian JK; Hiemenz M; Duncan D; Lin DI; Dennis L; Aiyer A; Gjoerup O; Oxnard G; Venstrom J; Elvin J; Ramkissoon SH; Ross JS
    Clin Chem; 2021 Nov; 67(11):1554-1566. PubMed ID: 34626187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing.
    Guo Q; Wang J; Xiao J; Wang L; Hu X; Yu W; Song G; Lou J; Chen J
    Mol Cancer; 2018 Aug; 17(1):131. PubMed ID: 30153823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation.
    Dao J; Conway PJ; Subramani B; Meyyappan D; Russell S; Mahadevan D
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA.
    Gawroński AR; Lin YY; McConeghy B; LeBihan S; Asghari H; Koçkan C; Orabi B; Adra N; Pili R; Collins CC; Sahinalp SC; Hach F
    Nucleic Acids Res; 2019 Apr; 47(7):e38. PubMed ID: 30759232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
    Deger T; Boers RG; de Weerd V; Angus L; van der Put MMJ; Boers JB; Azmani Z; van IJcken WFJ; Grünhagen DJ; van Dessel LF; Lolkema MPJK; Verhoef C; Sleijfer S; Martens JWM; Gribnau J; Wilting SM
    Clin Epigenetics; 2021 Oct; 13(1):196. PubMed ID: 34670587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing.
    Wong D; Moturi S; Angkachatchai V; Mueller R; DeSantis G; van den Boom D; Ehrich M
    Clin Biochem; 2013 Aug; 46(12):1099-1104. PubMed ID: 23643886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR.
    Norton SE; Lechner JM; Williams T; Fernando MR
    Clin Biochem; 2013 Oct; 46(15):1561-5. PubMed ID: 23769817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics.
    van Ginkel JH; van den Broek DA; van Kuik J; Linders D; de Weger R; Willems SM; Huibers MMH
    Cancer Med; 2017 Oct; 6(10):2297-2307. PubMed ID: 28940814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analytical and clinical validation of a novel amplicon-based NGS assay for the evaluation of circulating tumor DNA in metastatic colorectal cancer patients.
    Wang B; Wu S; Huang F; Shen M; Jiang H; Yu Y; Yu Q; Yang Y; Zhao Y; Zhou Y; Pan B; Liu T; Guo W
    Clin Chem Lab Med; 2019 Sep; 57(10):1501-1510. PubMed ID: 31339850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.
    Deans ZC; Butler R; Cheetham M; Dequeker EMC; Fairley JA; Fenizia F; Hall JA; Keppens C; Normanno N; Schuuring E; Patton SJ
    Virchows Arch; 2019 Jun; 474(6):681-689. PubMed ID: 31028539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours.
    Stankunaite R; George SL; Gallagher L; Jamal S; Shaikh R; Yuan L; Hughes D; Proszek PZ; Carter P; Pietka G; Heide T; James C; Tari H; Lynn C; Jain N; Portela LR; Rogers T; Vaidya SJ; Chisholm JC; Carceller F; Szychot E; Mandeville H; Angelini P; Jesudason AB; Jackson M; Marshall LV; Gatz SA; Anderson J; Sottoriva A; Chesler L; Hubank M
    Eur J Cancer; 2022 Feb; 162():209-220. PubMed ID: 34933802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotyping of circulating cell-free DNA enables noninvasive tumor detection in myxoid liposarcomas.
    Braig D; Becherer C; Bickert C; Braig M; Claus R; Eisenhardt AE; Heinz J; Scholber J; Herget GW; Bronsert P; Fricke A; Follo M; Stark GB; Bannasch H; Eisenhardt SU
    Int J Cancer; 2019 Aug; 145(4):1148-1161. PubMed ID: 30779112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of Preanalytic and Analytic Variables for Clinical Next-Generation Sequencing of Circulating Cell-Free Nucleic Acid.
    Mehrotra M; Singh RR; Chen W; Huang RSP; Almohammedsalim AA; Barkoh BA; Simien CM; Hernandez M; Behrens C; Patel KP; Routbort MJ; Broaddus RR; Medeiros LJ; Wistuba II; Kopetz S; Luthra R
    J Mol Diagn; 2017 Jul; 19(4):514-524. PubMed ID: 28506684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer.
    Vitale SR; Helmijr JA; Gerritsen M; Coban H; van Dessel LF; Beije N; van der Vlugt-Daane M; Vigneri P; Sieuwerts AM; Dits N; van Royen ME; Jenster G; Sleijfer S; Lolkema M; Martens JWM; Jansen MPHM
    BMC Cancer; 2021 Mar; 21(1):315. PubMed ID: 33761899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of surgical trauma on circulating free DNA levels in cancer patients-implications for studies of circulating tumor DNA.
    Henriksen TV; Reinert T; Christensen E; Sethi H; Birkenkamp-Demtröder K; Gögenur M; Gögenur I; Zimmermann BG; ; Dyrskjøt L; Andersen CL
    Mol Oncol; 2020 Aug; 14(8):1670-1679. PubMed ID: 32471011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions.
    Sorber L; Zwaenepoel K; Jacobs J; De Winne K; Van Casteren K; Augustus E; Lardon F; Prenen H; Peeters M; Van Meerbeeck J; Roeyen G; Rolfo C; Pauwels P
    Mol Diagn Ther; 2020 Feb; 24(1):113-124. PubMed ID: 31838654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of Preanalytical Variables Impacting Pathogen Cell-Free DNA in Blood and Urine.
    Murugesan K; Hogan CA; Palmer Z; Reeve B; Theron G; Andama A; Somoskovi A; Steadman A; Madan D; Andrews J; Croda J; Sahoo MK; Cattamanchi A; Pinsky BA; Banaei N
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31511335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.